Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (NCT06466434) investigating a prebiotic food-enriched diet to enhance the microbiome and improve response to first-line immunotherapy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Unresectable Melanoma | Phase 2 | Status: RECRUITING